Armata Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 05/09/2025 | 260.07 K | $379.71 K | 11.09% | 0.72% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 105.84 K | $154.57 K | -0.89% | 0.29% |
| EDGEWOOD MANAGEMENT LLC | 05/14/2025 | 100.00 K | $146.00 K | 0.00% | 0.28% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 05/15/2025 | 44.68 K | $65.24 K | -35.88% | 0.12% |
| STATE STREET CORP | 05/15/2025 | 40.30 K | $58.84 K | 0.00% | 0.11% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2025 | 38.60 K | $56.35 K | -4.21% | 0.11% |
| SEACREST WEALTH MANAGEMENT, LLC | 04/11/2025 | 34.95 K | $51.03 K | 0.00% | 0.10% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 27.68 K | $40.41 K | -44.40% | 0.08% |
| BLACKROCK, INC. | 05/02/2025 | 23.18 K | $33.85 K | -1.87% | 0.06% |
| CITADEL ADVISORS LLC | 05/15/2025 | 20.59 K | $30.07 K | 100.00% | 0.06% |
| NORTHERN TRUST CORP | 05/13/2025 | 19.27 K | $28.14 K | 0.00% | 0.05% |
| CAPTRUST FINANCIAL ADVISORS | 05/15/2025 | 13.14 K | $19.18 K | 0.00% | 0.04% |
| GROUP ONE TRADING, L.P. | 05/14/2025 | 4.80 K | $7.01 K | -58.69% | 0.01% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2025 | 3.47 K | $5.07 K | 4.80% | 0.01% |
| UBS GROUP AG | 05/13/2025 | 1.75 K | $2.55 K | -72.34% | 0.00% |
| CITADEL ADVISORS LLC | 05/15/2025 | 1.00 K | $1.46 K | 100.00% | 0.00% |
| TRIFECTA CAPITAL ADVISORS, LLC | 04/21/2025 | 714 | $1.04 K | 0.00% | 0.00% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 05/14/2025 | 571 | $834 | 0.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 05/12/2025 | 357 | $521 | 100.00% | 0.00% |
| CITADEL ADVISORS LLC | 05/15/2025 | 300 | $438 | 100.00% | 0.00% |
| MORGAN STANLEY | 05/15/2025 | 109 | $159 | 0.00% | 0.00% |
| SALEM INVESTMENT COUNSELORS INC | 04/16/2025 | 100 | $146 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 05/15/2025 | 93 | $136 | -99.99% | 0.00% |
| MAI CAPITAL MANAGEMENT | 05/15/2025 | 71 | $104 | 0.00% | 0.00% |
| JPMORGAN CHASE & CO | 05/12/2025 | 22 | $32 | -12.00% | 0.00% |
| 05/02/2025 | 3 | $4 | 0.00% | 0.00% | |
| WELLS FARGO & COMPANY/MN | 05/13/2025 | 1 | $1 | 0.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Armata Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 24 institutional investors and hedge funds held shares of Armata Pharmaceuticals, Inc.. The most heavily invested institutionals were:
VANGUARD GROUP INC: 260,073
GEODE CAPITAL MANAGEMENT, LLC: 105,837
EDGEWOOD MANAGEMENT LLC: 100,000
BRIDGEWAY CAPITAL MANAGEMENT, LLC: 44,682
STATE STREET CORP: 40,300
RENAISSANCE TECHNOLOGIES LLC: 38,596
2.05% of Armata Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 728.29 K shares in the last 24 months. This purchase volume represents approximately $1.76 M in transactions.